These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 21162693)

  • 1. Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction.
    Zhang JP; Malhotra AK
    Expert Opin Drug Metab Toxicol; 2011 Jan; 7(1):9-37. PubMed ID: 21162693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics of antipsychotics: recent progress and methodological issues.
    Zhang JP; Malhotra AK
    Expert Opin Drug Metab Toxicol; 2013 Feb; 9(2):183-91. PubMed ID: 23199282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics and antipsychotics in the light of personalized pharmacotherapy.
    Mihaljević-Peles A; Sagud M; Bozina N; Zivković M; Jovanović N
    Psychiatr Danub; 2010 Jun; 22(2):335-7. PubMed ID: 20562776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Genetic Variants of Dopamine and Serotonin In Schizophrenia.
    Zakharyan R; Ghazaryan H; Kocourkova L; Chavushyan A; Mkrtchyan A; Zizkova V; Arakelyan A; Petrek M
    Arch Med Res; 2020 Jan; 51(1):13-20. PubMed ID: 32086104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personalized antipsychotic treatment: the adverse effects perspectives.
    Plesnicar BK
    Psychiatr Danub; 2010 Jun; 22(2):329-34. PubMed ID: 20562775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research.
    Arranz MJ; de Leon J
    Mol Psychiatry; 2007 Aug; 12(8):707-47. PubMed ID: 17549063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetics and schizophrenia.
    Foster A; Miller DD; Buckley PF
    Psychiatr Clin North Am; 2007 Sep; 30(3):417-35. PubMed ID: 17720030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics and antipsychotic treatment response.
    Naumovska Z; Nestorovska AK; Filipce A; Sterjev Z; Brezovska K; Dimovski A; Suturkova LJ
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(1):53-67. PubMed ID: 26076775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics of Antipsychotic Treatment in Schizophrenia.
    Elsheikh SSM; Müller DJ; Pouget JG
    Methods Mol Biol; 2022; 2547():389-425. PubMed ID: 36068471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics of response to antipsychotics in patients with schizophrenia.
    Arranz MJ; Rivera M; Munro JC
    CNS Drugs; 2011 Nov; 25(11):933-69. PubMed ID: 22054119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Brain neurotransmitter systems gene Polymorphism: the Search for pharmacogenetic markers of efficacy of haloperidol in Russians and Tatars].
    Gareeva AE; Kinyasheva KO; Galaktionova DY; Sabirov ET; Valinourov RG; Chudinov AV; Zasedatelev AS; Nasedkina TV; Khusnutdinova EK
    Mol Biol (Mosk); 2015; 49(6):959-67. PubMed ID: 26710776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pharmacogenetic intervention for the improvement of the safety profile of antipsychotic treatments.
    Arranz MJ; Gonzalez-Rodriguez A; Perez-Blanco J; Penadés R; Gutierrez B; Ibañez L; Arias B; Brunet M; Cervilla J; Salazar J; Catalan R
    Transl Psychiatry; 2019 Jul; 9(1):177. PubMed ID: 31346157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenomics can improve antipsychotic treatment in schizophrenia.
    Xu Q; Wu X; Xiong Y; Xing Q; He L; Qin S
    Front Med; 2013 Jun; 7(2):180-90. PubMed ID: 23606027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical pharmacogenetics in the treatment of schizophrenia].
    Saito M; Yasui-Furukori N; Kaneko S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2005 Jun; 25(3):129-35. PubMed ID: 16045195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics as a tool in the therapy of schizophrenia.
    Wilffert B; Zaal R; Brouwers JR
    Pharm World Sci; 2005 Feb; 27(1):20-30. PubMed ID: 15861931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomics in schizophrenia: the quest for individualized therapy.
    Basile VS; Masellis M; Potkin SG; Kennedy JL
    Hum Mol Genet; 2002 Oct; 11(20):2517-30. PubMed ID: 12351588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COMT val158met moderation of dopaminergic drug effects on cognitive function: a critical review.
    Schacht JP
    Pharmacogenomics J; 2016 Oct; 16(5):430-8. PubMed ID: 27241058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P450 testing for prescribing antipsychotics in adults with schizophrenia: systematic review and meta-analyses.
    Fleeman N; Dundar Y; Dickson R; Jorgensen A; Pushpakom S; McLeod C; Pirmohamed M; Walley T
    Pharmacogenomics J; 2011 Feb; 11(1):1-14. PubMed ID: 20877299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics of antipsychoatics.
    Ozaki N
    Nagoya J Med Sci; 2004 May; 67(1-2):1-7. PubMed ID: 15279062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The AmpliChip CYP450 genotyping test: Integrating a new clinical tool.
    de Leon J; Susce MT; Murray-Carmichael E
    Mol Diagn Ther; 2006; 10(3):135-51. PubMed ID: 16771600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.